Kangji Medical Holdings Limited (FRA:50J)

Market Cap	1.04B
Revenue (ttm)	133.47M
Net Income (ttm)	76.94M
Shares Out	n/a
EPS (ttm)	0.07
PE Ratio	13.46
Forward PE	n/a
Dividend	0.18 (22.22%)
Ex-Dividend Date	May 27, 2025

Volume	n/a
Average Volume	18
Open	0.8150
Previous Close	0.8250
Day's Range	0.8150 - 0.8150
52-Week Range	0.5550 - 0.9600
Beta	n/a
RSI	50.69
Earnings Date	May 20, 2025

About Kangji Medical Holdings

Kangji Medical Holdings Limited, an investment holding company, engages in the design, development, manufacture, and sale of minimally invasive surgical instruments and accessories in Mainland China and internationally. The company offers disposable consumables, such as trocars, uterine manipulator, specimen retrieval bag, incision dilator, powered linear stapler and reloads, endoscopic stapler, suction and irrigation sets, closure forceps, and visual guidance D and C suction probe, as well as polymer ligation clips. It provides disposable elec...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2004
• Employees: 1,007
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 50J

Financial Performance

In 2024, Kangji Medical Holdings's revenue was 1.01 billion, an increase of 8.92% compared to the previous year's 926.02 million. Earnings were 581.44 million, an increase of 15.36%.

Financial numbers in CNY